Progress in vaccine development for infectious diseases—a Keystone Symposia report
Jennifer Cable(New York Academy of Sciences), Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Jason S. McLellan(The University of Texas at Austin), Michael Schotsaert(Icahn School of Medicine at Mount Sinai), Syed M. Moin(National Institutes of Health), Kwinten Sliepen(Amsterdam University Medical Centers), Hedda Wardemann(German Cancer Research Center), Neil P. King(University of Washington), Julia Lederhofer(National Institutes of Health), Richard A. Koup(Aaron Diamond AIDS Research Center), Barney S. Graham(National Institutes of Health), Mattias N.E. Forsell(Umeå University), Raffael Nachbagauer(Moderna Therapeutics (United States)), Ali H. Ellebedy(Washington University in St. Louis), Katalin Karikó(BioNTech (Germany)), Elizabeth A. Thompson(North Carolina State University), Bali Pulendran(Palo Alto University), Lisa C. Lindesmith(University of North Carolina at Chapel Hill), Jennifer A. Juno(The University of Melbourne), Dan H. Barouch(Beth Israel Deaconess Medical Center), Laura M. Walker(Children's Hospital of Philadelphia), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Karin Loré(Karolinska University Hospital), Robert A. Seder(National Institutes of Health), Norbert Pardi(University of Pennsylvania), Kevin O. Saunders(Duke University), Siri Tähtinen, Emily H. Pilkington(The University of Melbourne), Gunilla B. Karlsson Hedestam(Science for Life Laboratory), Yanis Feraoun(Inserm), Holger Wille(University of California, San Francisco), Sila Ataca(National Institutes of Health), Nicole A. Doria‐Rose(National Institutes of Health), Peter J. Hotez(Baylor College of Medicine), Darrell J. Irvine(Howard Hughes Medical Institute), Bhawna Sharma(Gilead Sciences (United States)), Susanne Rauch(CureVac (Germany)), Wan‐Ting He(Scripps Research Institute), Adam K. Wheatley(The University of Melbourne)
Cited by 7
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
|JAMA Oncology|2017|2k
T-cell quality in memory and protection: implications for vaccine design
|Nature reviews. Immunology|2008|1.6k